Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Discovery In Talks With Government Over Vaccination Rollout

Published 2021/04/01, 08:56
Updated 2021/04/01, 09:00
Discovery In Talks With Government Over Vaccination Rollout
DSBPp
-

Share with your network! Discovery (JO:DSBPp) Health says it expects to start vaccinating about 55,000 at-risk clients from May.

This forms part of the second phase of the nationwide vaccination programme.

Discovery Health CEO Dr Ryan Noach said the vaccines will be free to the medical scheme’s members.

“We’ll be ready by 1 May in order to commence that vaccination process.”

“Cabinet’s announcement confirmed the private sector will be involved from May and we are closely involved in a conversation with the Department of Health to understand how the vaccine allocations will work,” he said.

“It’s very important that we get the most at risk vaccinated quickly and so we are doing all we can, working with the Department of Health, to get those supplies in early so that the most at risk can be done by mid-winter we hope.”

Share with your network! The post Discovery In Talks With Government Over Vaccination Rollout appeared first on iAfrica.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.